September 2024 PMID 39629036

Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis.

Liu Yang, Xueyu Duan, Peng Hua, Shilin Wu, Xiaobo Liu

Mentions

3
Peak: 1 in Dec 2024
across 2 sources since Dec 2024

Extended reach

19,236
potential audience

Total likes

23

Video views

239

Mentions per month

Dec 2024 – Mar 2025

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions demonstrate strong support and interest, with phrases like 'game-changing' and 'must consider' indicating enthusiasm about semaglutide's potential. Engagement is shown through referencing study data and implications, highlighting the publication's high relevance and potential impact on medical approaches to obesity and diabetes.

AgreementModerate agreement

Most discussions acknowledge and support the findings of the publication, highlighting its significance in weight management and diabetes care.

InterestHigh interest

Posts show high interest, with many referencing the potential of semaglutide to revolutionize treatment and mentioning its effectiveness in achieving substantial weight loss.

EngagementModerate engagement

Participants engage by discussing study details and implications, indicating a moderate depth of analysis and reflection on the research's significance.

ImpactHigh impact

The discourse suggests that the publication could influence clinical practices and future research, emphasizing its importance in medical treatment strategies.

Abstract in brief

  • The study aimed to assess the effectiveness and safety of semaglutide for weight loss in overweight or obese adults, including those with type 2 diabetes.
  • A systematic review and meta-analysis of 15 randomized controlled trials involving nearly 7000 participants were conducted, examining various health metrics such as body weight, body mass index, and blood glucose levels.
  • Results showed that semaglutide significantly reduced weight and improved other health markers compared to control groups, with a notable percentage of patients achieving substantial weight loss.

Top posts

Most liked on X and Bluesky
Nick Krontiris
@nick_krontiris · X

Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis (open access) https://t.co/Vr54zoPW3t

Dec 11, 2024 · 1 like · 18,998 followers View post →

All mentions

Nick Krontiris
@nick_krontiris · X

Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis (open access) https://t.co/Vr54zoPW3t

Dec 11, 2024 · 1 like · 18,998 followers View post →